Lineage Cell Therapeutics Inc (LCTX) has gained Monday morning, with the stock rising 3.05% in pre-market trading to 1.69. LCTX's short-term technical score of 31 indicates that the stock has traded less bullishly over the last month than 69% of stocks on the market. In the Biotechnology industry, which ranks 75 out of 146 industries, the stock ranks higher than 22% of stocks. Lineage Cell Therapeutics Inc has risen 4.46% over the past month, closing at $1.69 on July 4. During this period of time, the stock fell as low as $1.57 and as high as $1.76. LCTX has an average analyst recommendation of Strong Buy. The company has an average price target of $6.00.
LCTX has an Overall Score of 69. Find out what this means to you and get the rest of the rankings on LCTX!